126 related articles for article (PubMed ID: 38582699)
1. Aromatic Amino Acids Promote Lipid Metabolism Disorders by Increasing Hepatic Bile Acid Synthesis.
Chen J; Qin Y; Li Z; Shan A; Ma Q
J Nutr; 2024 Apr; 154(4):1321-1332. PubMed ID: 38582699
[TBL] [Abstract][Full Text] [Related]
2. Lactoferrin promotes bile acid metabolism and reduces hepatic cholesterol deposition by inhibiting the farnesoid X receptor (FXR)-mediated enterohepatic axis.
Ling CJ; Xu JY; Li YH; Tong X; Yang HH; Yang J; Yuan LX; Qin LQ
Food Funct; 2019 Nov; 10(11):7299-7307. PubMed ID: 31626262
[TBL] [Abstract][Full Text] [Related]
3. FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by
Ye X; Huang D; Dong Z; Wang X; Ning M; Xia J; Shen S; Wu S; Shi Y; Wang J; Wan X
Microbiol Spectr; 2022 Oct; 10(5):e0051822. PubMed ID: 36036629
[TBL] [Abstract][Full Text] [Related]
4. Apple Polyphenol Extract Improves High-Fat Diet-Induced Hepatic Steatosis by Regulating Bile Acid Synthesis and Gut Microbiota in C57BL/6 Male Mice.
Li D; Cui Y; Wang X; Liu F; Li X
J Agric Food Chem; 2021 Jun; 69(24):6829-6841. PubMed ID: 34124904
[TBL] [Abstract][Full Text] [Related]
5. L-Theanine regulates lipid metabolism by modulating gut microbiota and bile acid metabolism.
Xu W; Kong Y; Zhang T; Gong Z; Xiao W
J Sci Food Agric; 2023 Feb; 103(3):1283-1293. PubMed ID: 36087337
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of intestinal FXR activity as a possible mechanism for the beneficial effects of a probiotic mix supplementation on lipid metabolism alterations and weight gain in mice fed a high fat diet.
Beau A; Benoit B; Le Barz M; Meugnier E; Penhoat A; Calzada C; Pinteur C; Loizon E; Chanon S; Vieille-Marchiset A; Sauvinet V; Godet M; Laugerette F; Holowacz S; Jacouton E; Michalski MC; Vidal H
Gut Microbes; 2023 Dec; 15(2):2281015. PubMed ID: 37985749
[TBL] [Abstract][Full Text] [Related]
7. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
[TBL] [Abstract][Full Text] [Related]
8. The water extract of Radix scutellariae, its total flavonoids and baicalin inhibited CYP7A1 expression, improved bile acid, and glycolipid metabolism in T2DM mice.
Yan X; Zhang Y; Peng Y; Li X
J Ethnopharmacol; 2022 Jul; 293():115238. PubMed ID: 35351576
[TBL] [Abstract][Full Text] [Related]
9. Nuciferine Protects Against High-Fat Diet-Induced Hepatic Steatosis
Sun J; Fan J; Li T; Yan X; Jiang Y
J Agric Food Chem; 2022 Sep; 70(38):12014-12028. PubMed ID: 36106619
[TBL] [Abstract][Full Text] [Related]
10. The protective mechanism of Lactobacillus plantarum FZU3013 against non-alcoholic fatty liver associated with hyperlipidemia in mice fed a high-fat diet.
Chen M; Guo WL; Li QY; Xu JX; Cao YJ; Liu B; Yu XD; Rao PF; Ni L; Lv XC
Food Funct; 2020 Apr; 11(4):3316-3331. PubMed ID: 32226996
[TBL] [Abstract][Full Text] [Related]
11. Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
Liu Y; Chen K; Li F; Gu Z; Liu Q; He L; Shao T; Song Q; Zhu F; Zhang L; Jiang M; Zhou Y; Barve S; Zhang X; McClain CJ; Feng W
Hepatology; 2020 Jun; 71(6):2050-2066. PubMed ID: 31571251
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.
Rao A; Kosters A; Mells JE; Zhang W; Setchell KD; Amanso AM; Wynn GM; Xu T; Keller BT; Yin H; Banton S; Jones DP; Wu H; Dawson PA; Karpen SJ
Sci Transl Med; 2016 Sep; 8(357):357ra122. PubMed ID: 27655848
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
[TBL] [Abstract][Full Text] [Related]
14. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
[TBL] [Abstract][Full Text] [Related]
15. Diet-induced obesity and weight loss alter bile acid concentrations and bile acid-sensitive gene expression in insulin target tissues of C57BL/6J mice.
La Frano MR; Hernandez-Carretero A; Weber N; Borkowski K; Pedersen TL; Osborn O; Newman JW
Nutr Res; 2017 Oct; 46():11-21. PubMed ID: 29173647
[TBL] [Abstract][Full Text] [Related]
16. Neurotensin differentially regulates bile acid metabolism and intestinal FXR-bile acid transporter axis in response to nutrient abundance.
Li J; Song J; Yan B; Weiss HL; Weiss LT; Gao T; Evers BM
FASEB J; 2021 May; 35(5):e21371. PubMed ID: 33811694
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Bile Acid Metabolism and Gut Microbiota in the Amelioration of Experimental Metabolism-Associated Fatty Liver Disease by Nobiletin.
Xu H; Yuan M; Niu K; Yang W; Jiang M; Zhang L; Zhou J
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474489
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity.
Mueller M; Thorell A; Claudel T; Jha P; Koefeler H; Lackner C; Hoesel B; Fauler G; Stojakovic T; Einarsson C; Marschall HU; Trauner M
J Hepatol; 2015 Jun; 62(6):1398-404. PubMed ID: 25617503
[TBL] [Abstract][Full Text] [Related]
19. Capsaicin Improves Glucose Tolerance and Insulin Sensitivity Through Modulation of the Gut Microbiota-Bile Acid-FXR Axis in Type 2 Diabetic db/db Mice.
Hui S; Liu Y; Chen M; Wang X; Lang H; Zhou M; Yi L; Mi M
Mol Nutr Food Res; 2019 Dec; 63(23):e1900608. PubMed ID: 31539192
[TBL] [Abstract][Full Text] [Related]
20. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
